Sixteen U.S. senators today urged the Department of Health and Human Services to take immediate action to reduce the price of naloxone – a drug that can be delivered via nasal mist or injection to temporarily suspend the effects of an overdose until emergency responders arrive. “No police officer, no firefighter, no public health provider, and no person should be unable to save a life because of the high price,” the senators wrote to HHS Secretary Alex Azar. “By bringing down the cost, we can get this life-saving drug in the hands of more people as called for by the Surgeon General. Doing so will save countless lives.” Earlier this month, U.S. Surgeon General Jerome Adams, M.D., issued a public health advisory urging Americans who misuse opioids, have an opioid use disorder or recent overdose, or know someone who does, to carry and know how to use naloxone.

Related News Articles

Headline
A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company…
Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…
Perspective
Investing in our country’s health infrastructure is the right move to make.